Notably, while elevated GDF15 is widely recognized as a powerful prognostic biomarker for adverse outcomes in cardiovascular diseases such as MI [24, 25], a growing body of evidence indicates it also exerts direct cardioprotective effects against insults like pathological hypertrophy [26]. The gene discussed is GDF15; the disease is cardiovascular disorder.